Edgewise Therapeutics, Inc.
EWTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001710072
In the last 90 days, Edgewise Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.82B in total; no superinvestor holds it.
13F holders, Q1 2021
Institutional positions in Edgewise Therapeutics, Inc. as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- No complete 13F data for Q4 2020
- Shares held
- 45.7M
- No complete 13F data for Q4 2020
- Total value
- $1.48B
- No complete 13F data for Q4 2020
Holders and value by quarter
Institutions reporting EWTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 226 | $4.82B |
| Q1 2026 | 214 | $3.72B |
| Q4 2025 | 199 | $3.02B |
| Q3 2025 | 173 | $1.82B |
| Q2 2025 | 179 | $1.56B |
| Q1 2025 | 193 | $2.32B |
| Q4 2024 | 201 | $2.64B |
| Q3 2024 | 177 | $2.71B |
| Q2 2024 | 140 | $1.83B |
| Q1 2024 | 129 | $1.67B |
| Q4 2023 | 116 | $871.4M |
| Q3 2023 | 85 | $392.2M |
| Q2 2023 | 95 | $538.8M |
| Q1 2023 | 85 | $443.1M |
| Q4 2022 | 90 | $594.1M |
| Q3 2022 | 94 | $633.5M |
| Q2 2022 | 78 | $405.7M |
| Q1 2022 | 72 | $523.5M |
| Q4 2021 | 58 | $769.4M |
| Q3 2021 | 48 | $795.8M |
| Q2 2021 | 46 | $1.03B |
| Q1 2021 | 31 | $1.48B |
Institutions, Q1 2021
Shares, value and share of portfolio for each institution holding Edgewise Therapeutics, Inc..
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Maven Securities LTD | 8,300 | $262.0K | 0.02% | – | – |
| Landscape Capital Management, L.L.C. | 8,923 | $290.0K | 0.05% | – | – |
| Squarepoint Ops LLC | 20,185 | $656.0K | 0.01% | – | – |
| Caas Capital Management LP | 30,000 | $975.0K | 0.03% | – | – |
| BlackRock Inc. | 55,485 | $1.80M | 0.00% | – | – |
| Millennium Management LLC | 60,077 | $1.95M | 0.00% | – | – |
| Goldman Sachs Group Inc | 65,263 | $2.12M | 0.00% | – | – |
| Credit Suisse AG | 84,052 | $2.73M | 0.00% | – | – |
| Sphera Funds Management Ltd. | 100,000 | $3.25M | 0.30% | – | – |
| Soleus Capital Management, L.P. | 100,000 | $3.25M | 0.59% | – | – |
| Vanguard Group Inc | 120,000 | $3.90M | 0.00% | – | – |
| Octagon Capital Advisors LP | 125,000 | $4.06M | 1.53% | – | – |
| American Century Companies Inc | 278,577 | $9.05M | 0.01% | – | – |
| Adage Capital Partners GP, L.L.C. | 300,000 | $9.75M | 0.02% | – | – |
| Woodline Partners LP | 357,429 | $11.6M | 0.26% | – | – |
| Norges Bank | 449,000 | $14.6M | 0.00% | – | – |
| Baker Bros. Advisors LP | 500,000 | $16.3M | 0.07% | – | – |
| Federated Hermes, Inc. | 616,724 | $20.0M | 0.04% | – | – |
| Wellington Management Group LLP | 742,412 | $23.1M | 0.00% | – | – |
| Logos Global Management LP | 1,056,812 | $34.3M | 3.35% | – | – |
| EcoR1 Capital, LLC | 1,224,175 | $39.8M | 1.78% | – | – |
| FMR LLC | 1,530,418 | $49.7M | 0.00% | – | – |
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $50.5M | 11.75% | – | – |
| Janus Henderson Group PLC | 2,140,908 | $65.1M | 0.03% | – | – |
| Cormorant Asset Management, LP | 2,340,914 | $74.3M | 2.14% | – | – |
| Citadel Advisors LLC | 2,382,148 | $77.4M | 0.08% | – | – |
| Ra Capital Management, L.P. | 2,613,623 | $84.9M | 1.28% | – | – |
| Viking Global Investors LPSuperinvestorViking Global Investors | 3,352,249 | $108.9M | 0.32% | – | – |
| Deerfield Management Company, L.P. (Series C) | 3,933,137 | $127.8M | 2.69% | – | – |
| Novo Holdings A/S | 5,587,207 | $181.6M | 7.50% | – | – |
| OrbiMed Advisors LLC | 13,944,680 | $453.2M | 4.28% | – | – |